Skip Navigation


Carcinogenesis Advance Access originally published online on May 17, 2007
Carcinogenesis 2007 28(11):2367-2374; doi:10.1093/carcin/bgm119
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
28/11/2367    most recent
bgm119v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by De Miglio, M. R.
Right arrow Articles by Feo, F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by De Miglio, M. R.
Right arrow Articles by Feo, F.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2007. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Identification and chromosome mapping of loci predisposing to colorectal cancer that control Wnt/ß-catenin pathway and progression of early lesions in the rat

Maria R. De Miglio, Patrizia Virdis, Diego F. Calvisi, Daniela Mele, Maria R. Muroni, Maddalena Frau, Federico Pinna, Maria L. Tomasi, Maria M. Simile, Rosa M. Pascale and Francesco Feo*

Department of Biomedical Sciences, Division of Experimental Pathology and Oncology, University of Sassari, 07100 Sassari, Italy

* To whom correspondence should be addressed. Tel: +0039 079 228307; Fax: +0039 079 228485; Email: feo{at}uniss.it

Sporadic colorectal cancer (CRC) is a major health concern worldwide. Epidemiologic evidence suggests a polygenic predisposition to CRC, but the genes responsible remain unknown. Here, we performed genome-wide scanning of male (ACI/SegHsd x Wistar-Furth)F2 (AWF2) rats to map susceptibility genes influencing the evolution of early colorectal lesions to adenocarcinoma following 1,2-dimethylhydrazine administration. Phenotypic analysis revealed higher incidence/multiplicity and lower size of adenomas in ACI/SegHsd (ACI) and (ACI/SegHsd x Wistar-Furth)F1 (AWF1) than Wistar-Furth (WF) rats and higher incidence/multiplicity of poorly differentiated adenocarcinomas in WF than ACI rats, with intermediate values in AWF1 rats. Linkage analysis of 138 AWF2 rats identified three loci on chromosomes 4, 15 and 18 in significant linkage with lesion multiplicity that were identified as rat Colon cancer resistance (rCcr) 1, rCcr2 and rCcr3, respectively. Seven other loci on chromosomes 5, 6, 15, 17, 18 and 20 were in suggestive linkage with adenoma/adenocarcinoma multiplicity/surface area. Six of them were identified as rCcr4–9 and a locus on chromosome 5 was identified as a susceptibility locus, rCcs1. Significant interactions between rCcr3 and rCcr6, rCcr6 and rCcr8 and rCcr5 and rCcr9, and four novel epistatic loci controlling multiplicity/size of colorectal lesions were discovered. Apc, located at rCcr3, did not show functional promoter polymorphisms. However, influence of susceptibility/resistance genes on Wnt/ß-catenin pathway was shown by defective ß-catenin inactivation in WF but not in ACI and AWF1 rat adenocarcinomas. These data indicate that inheritance of predisposition to CRC depends on interplays of several genetic factors, and suggest a possible mechanism of polygenic control of CRC progression.

Abbreviations: ACF, aberrant crypt focus; ACI, ACI/SegHsd; ANOVA, analysis of variance; APC, adenomatous polyposis coli; AWF1, (ACI/SegHsd x Wistar-Furth)F1; AWF2, (ACI/SegHsd x Wistar-Furth)F2; CRC, colorectal cancer; DMH, 1,2-dimethylhydrazine; LoD, logarithm of differences; PCR, polymerase chain reaction; PD, poorly differentiated; QTL, quantitative trait locus; rCcr, rat colorectal cancer resistance; rCcs, rat colorectal cancer susceptibility; Scc, susceptibility to colon cancer; WD, well differentiated; WF, Wistar-Furth

Received February 1, 2007; revised May 8, 2007; accepted May 12, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.